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Abstract
Introduction
Alcohol consumption is a factor that increases risk of
chronic disease. This study estimates various indicators of
alcohol-attributable premature chronic-disease morbidity
and mortality for Canada in 2002.
Methods
Information on mortality and morbidity was obtained
from Statistics Canada and from the Canadian Institute
for Health Information database. Data on alcohol use
were obtained from the Canadian Addiction Survey and
weighted for per capita consumption. Risk information
was taken from published literature and combined with
alcohol consumption information to calculate age- and
sex-specific alcohol-attributable chronic disease morbidity
and mortality.
Results
In Canada in 2002, there were 1631 chronic disease
deaths among adults aged 69 years and younger attributed
to alcohol consumption, and these deaths were 2.4% of the
deaths in Canada for this age group. The net number of
deaths comprised 2577 deaths caused and 947 deaths pre-
vented by alcohol consumption. Moderate drinking was
involved in 25% of deaths caused and 85% of deaths pre-
vented by alcohol. There were 42,996 years of life lost pre-
maturely in Canada due to alcohol consumption in 2002,
28,890 for men and 14,106 for women. In Canada in 2002,
there were 91,970 net chronic disease hospitalizations
attributed to alcohol consumption among individuals aged
69 years and younger. The net numbers were 124,621 hos-
pitalizations caused and 32,651 hospitalizations prevented
by alcohol consumption.
Conclusion
With rising rates of alcohol consumption and extensive
high-risk drinking, both chronic and acute damage from
alcohol are expected to increase. Attention is needed to 1)
create effective policies and interventions; 2) control access
to alcohol; 3) reduce high-risk drinking; and 4) provide
brief interventions for high-risk drinkers.
Introduction
According to recent studies by the World Health
Organization, alcohol consumption is a leading contributor
to chronic disease and is recognized as a strong risk factor
affecting health in developed countries such as the United
States and Canada (1-3). In terms of global burden of dis-
ease, about 4% of disability-adjusted life years (DALYs)
worldwide in the year 2000 were attributable to alcohol. In
developed countries, the percentage is still higher with
ranges for men from 8% to 18% and ranges for women 2%
to 4% in the Americas and Europe (1). Chronic diseases
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such as cancer, liver cirrhosis, cardiovascular diseases,
neuropsychiatric conditions, and gastrointestinal diseases
are affected by alcohol consumption and contribute to
global disease burden (3,4). In Canada, aggregate-level
studies focused on drinking and disease trends over the
past 50 years indicate a strong positive association
between average consumption levels and rates of alcohol-
attributable mortality (5), liver cirrhosis deaths (6), and
total mortality (7).
Both the volume of alcohol consumed and high-risk
drinking patterns were found to contribute to chronic dis-
ease and disability (8). In this study, the terms heavy
drinking occasion and high-risk drinking pattern are used
synonymously with binge drinking. High-risk drinking
patterns impact chronic diseases, especially ischemic or
other cardiovascular disease categories (9). Increased alco-
hol consumption, as well as increased high-risk drinking,
is expected to raise the burden of alcohol-attributable
chronic diseases in Canada.
Recorded adult per capita alcohol consumption increased
in Canada from 7.3 liters of absolute alcohol per person
aged 15 years and older in 1997 to 7.9 liters in 2004
(10,11). According to Canadian Community Health
Surveys, high-risk drinking (five or more drinks on one
occasion and 12 or more of these occasions in the past 12
months) has increased from about 11.4% in 1994 to 17.8%
in 2003 (age-standardized prevalence among the total pop-
ulation aged 15 years and older) (12,13).
Prevention strategies in Canada have not provided ade-
quate attention to the importance of appropriate prevention
of alcohol consumption (14). Even when reduction of alcohol
consumption is included in prevention strategies, evidence-
based effective prevention measures to reduce alcohol-
attributable harm, such as higher prices or brief interven-
tions by health care personnel, are often ignored (15).
The general public has little knowledge about the effects
of alcohol consumption on chronic diseases (16).
Increasing this knowledge should become a public health
priority for the following reasons: 1) epidemiological evi-
dence indicates alcohol consumption is a major health risk
factor in developed countries (1,3); 2) there is a strong
association between recent levels of increased drinking
and alcohol-attributable damage in Canada (10,11) and
other western countries; 3) damage from alcohol con-
sumption is expected to increase, so it is increasingly
important to develop and use evidence-based interven-
tions to reduce alcohol-attributable harm (15); and 4)
alcohol tends to be overlooked as a risk factor (17) in
chronic disease prevention initiatives in many western
countries. This study provides data on the impact of alco-
hol consumption on chronic diseases by showing estimat-
ed premature chronic-disease deaths and hospitalizations
caused by alcohol in Canada for the year 2002.
Methods
Determining chronic disease categories attributable to
alcohol
Chronic disease conditions attributable to alcohol were
identified through a review of epidemiological literature
that found most assessments converge on the chronic dis-
ease categories causally related to alcohol (3,9). This study
takes a conservative approach and includes only chronic
disease categories with an established biological pathway,
temporal order, consistent effects, and dose response rela-
tionships (18). Table 1 gives an overview of chronic condi-
tions identified. The meta-analyses reviewed to determine
the nature of the effect of alcohol on chronic conditions in
this study showed that the effect of alcohol consumption on
chronic diseases can be detrimental or, in some cases, ben-
eficial. The nature of the effect (detrimental or beneficial)
of alcohol on chronic conditions depends on the level of
alcohol consumed for some conditions, such as stroke (22)
or ischemic heart disease (3,21). Lower levels of consump-
tion have a beneficial effect; higher levels of consumption
have a detrimental effect. For type 2 diabetes mellitus
among men and cholelithiasis (i.e., gall bladder disease)
among both sexes, the effect is beneficial for all drinking
categories (Table 1). Either detrimental or beneficial
effects may be based on confounding phenomena (23),
which, in scientific literature, is discussed more for benefi-
cial than for detrimental effects.
Measurement of alcohol consumption
To measure level of alcohol consumption, we followed the
approach of English et al (24) and used four drinking cate-
gories based on average volume of alcohol consumed (Table
2). The four levels are 1) abstainer or very light drinker, 0
to less than .25 grams of alcohol per day for men and
women; 2) category I, .25 to less than 20 grams of alcohol
per day for women and .25 to less than 40 grams for men;
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3) category II, 20 to less than 40 grams of alcohol per day
for women and 40 to less than 60 grams for men; and 4)
category III, 40 grams of alcohol or more per day for
women and 60 grams or more for men. Most meta-analy-
ses have given relative risks based on these categories (9).
The prevalence data of different levels of alcohol con-
sumption were collected between 2003 and 2004 through
the Canadian Addiction Survey (CAS) (25) with a total
sample size of 13,909 (n = 5,721 men and n = 8,188 women)
and a 47% response rate. The CAS is a stratified (by
region) and randomized (by household and respondent)
telephone-based survey of the population aged 15 years
and older initiated by the Canadian Centre on Substance
Abuse (CCSA). This survey was used despite a relatively
low response rate because it had the necessary alcohol con-
sumption measures, a large sample size, and closest tem-
poral proximity to the mortality data provided by Statistics
Canada (27). It has previously been reported that higher
response rates in surveys did not essentially change distri-
bution results of alcohol consumption (28).
Characteristics of the CAS sample were weighted to cor-
respond to age and sex distribution of the Canadian popu-
lation. Average volume of alcohol consumption was derived
from a quantity frequency measure and adjusted by adult
per capita consumption (26). Quantity of alcohol was
assessed in beverage-specific drinks per usual occasion
(25). A per capita consumption adjustment was used
because it is considered the most valid choice for alcohol
consumption measurements for a population (28).
Measurements based on usual quantity and frequency
tend to underestimate alcohol consumption because
respondents do not usually include heavy drinking occa-
sions in their responses (29).
Mortality data 
Mortality data, with underlying cause of death coded
according to the International Classification of Diseases,
10th Revision (ICD-10), were obtained from Statistics
Canada for 2002 (27). Comparisons of causes of death in
the elderly have methodological problems; death certifi-
cates tend to be less valid for older individuals than for
younger individuals because multiple causes of death are
often involved (30,31). In this analysis, only data for those
aged 69 years and younger are included because there is
indication that relative risks, such as for ischemic heart
disease and for substance-attributable mortality and mor-
bidity, tend to converge with increasing age (26) and  to
result in overestimation of alcohol-attributable deaths
caused or prevented in older age groups.
Computing alcohol-attributable chronic-disease deaths
Alcohol-attributable fractions (AAFs) are generally
defined as the proportion of a disease in a population that
will disappear if alcohol is removed (32,33). AAFs for this
study were calculated from alcohol usage proportions in
Canada and disease- and sex-specific pooled relative risks
from previous meta-analyses (Table 1) and by using the
following formula:
AAF = [Σki = 1Pi(RRi – 1)]  / [Σki = 0 Pi(RRi – 1) + 1]
where i is the category with usage (i = 1) or no alcohol (i
= 0), RR(i) is the relative risk at exposure level i compared
with no alcohol consumption, P(i) is the prevalence of the
ith category of alcohol consumption, and k is the highest
drinking category (i.e., category III).
For each disease category, the sex- and age-group-specif-
ic AAFs were calculated as follows: the prevalence of alco-
hol consumption (exposure category) in the population was
multiplied with the excess risk (RR-1) for the given level of
alcohol consumption. The numerator in the formula repre-
sents the sum of all alcohol-attributable cases of a disease
by exposure category within a given sex- and age-group.
This sum is divided by all cases of a disease in the given
sex- and age-group to derive a proportion that is attributa-
ble to the exposure (i.e., alcohol consumption). The coun-
terfactual alternative in this conceptualization is no (or
zero) consumption. To derive estimates of the number of
deaths due to alcohol for a specific disease (by sex- and age-
group), the AAFs were then multiplied by the number of
deaths from that specific disease within the sex- and age-
group.
We cite a meta-analysis for each condition (e.g., malig-
nant neoplasms, type 2 diabetes mellitus, neuropsychiatric
conditions, cardiovascular diseases, digestive diseases)
(18) (Table 1) to derive information of relative risk for the
diverse categories. Meta-analyses usually cited are from
Gutjahr et al (19), a series of meta-analyses based on
English et al (24). The Gutjahr et al meta-analyses incor-
porate literature published since publication of the English
et al paper. For some disease categories, other meta-analy-
ses were cited if they were more comprehensive than the
VOLUME 3: NO. 4
OCTOBER 2006
www.cdc.gov/pcd/issues/2006/oct/05_0009.htm • Centers for Disease Control and Prevention 3
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
VOLUME 3: NO. 4
OCTOBER 2006
Gutjahr et al paper. For stroke, we based relative risks
on Reynolds et al (22) because, contrary to other authors,
this work separates ischemic and hemorrhagic stroke.
Alcohol usage has been shown to differentially influence
both types of stroke (3). For hemorrhagic stroke, the
effect of alcohol consumption, even at low levels, is detri-
mental for men (34); for women, the effect may be pro-
tective at low levels of drinking (categories I and II) (20),
but the effect depends on the pattern of drinking (35).
The effect of alcohol consumption on ischemic stroke is
partly protective for low to moderate consumption levels
(35), and the beneficial effect is more pronounced among
women. For depression data, we used mental health
surveys to estimate AAFs directly and took into consid-
eration the rates of comorbidity and time of onset for
alcohol use disorders and depression in comparison to
other mental diseases comorbid with alcohol (3).
No alcohol consumption was used as a counterfactual
scenario that was selected for the following reasons: 1) the
counterfactual of zero consumption is the most widely used
and allows comparisons with other studies; 2) the level of
alcohol associated with lowest burden differs from country
to country and is different for mortality and morbidity; 3)
alcohol-attributable harm is related to average volume of
alcohol consumption and consumption patterns; and 4)
selection of any volume of consumption other than zero
without considering the other dimensions would be arbi-
trary (36,37).
We calculated AAFs separately by sex and age (men and
women 15–29 years, 30–44 years, 45–59 years, 60–69
years). To show detrimental and beneficial effects of alco-
hol, we applied AAFs to Canadian mortality data (27) to
estimate the number of alcohol-attributed deaths by age
and sex. A negative AAF, in this case, means that more
deaths were prevented than caused by alcohol for the
respective disease condition (Table 3).
Potential Years of Life Lost
We hypothesized that persons dying due to alcohol con-
sumption would have lived longer if they had not con-
sumed alcohol. The average extra time such individuals
would have lived is known as residual life expectancy. If a
man died of alcoholic liver cirrhoses at age 50 in Canada,
he would have a residual life expectancy of 28.4 years (38).
The sum of residual life expectancies for people dying from
alcohol consumption is known as potential years of life lost
(PYLL) due to alcohol. PYLL for each sex- and age-group
can be estimated by interpolating the observed mean age
at death and the standard life expectancies tables for each
respective sex- and age-group. This study uses the World
Health Organization (WHO) 2000 standard life expectan-
cies table for Canada (38).
To calculate the mean ages within age intervals, we fol-
lowed rules specified by the WHO Global Burden of
Disease study (39). Canadian PYLL were calculated for
each age group (15–29, 30–44, 45–59, and 60–69) by mul-
tiplying the number of deaths by the interpolated life
expectancy for the observed mean age at death for the age
interval. The upper age limit of 76.0 years for men and
81.5 years for women was used to approximate Canadian
life expectancy at birth. PYLL were calculated per 100,000
population (Table 4).
Data on hospital diagnoses
Canadian fiscal year 2002 to 2003 hospital diagnoses
data (ICD-10) were obtained from the Canadian
Institute for Health Information (CIHI) Hospital
Morbidity Database (HMDB) for both national and
provincial levels (40). National data were available for
seven provinces (Alberta, British Columbia,
Newfoundland, Nova Scotia, Ontario, Prince Edward
Island, Saskatchewan) and two territories (Northwest
Territories and Yukon) and were provided for disease
conditions, and sex- and age-groups in 5-year segments.
Data for the provinces of Quebec, Manitoba, New
Brunswick, and Nunavut (a northern territory) were not
available according to ICD-10 classifications.
Aggregated data for each condition were estimated
based on total population and the combined data of
available provinces and territories. The HMDB captures
information on patients separated (through discharge or
death) from acute-care facilities in Canada and provides
national data on acute-care hospitalizations by diag-
noses and procedures. Diagnoses were categorized
based on most responsible diagnosis (MRD) of hospital-
ized patients. In cases where multiple diagnoses may be
classified as most responsible, the diagnosis associated
with the longest stay in a hospital was used. AAFs were
then applied to hospital data to estimate alcohol-attrib-
utable hospital diagnoses for each treatment facility by
age and sex.
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Results
Alcohol-attributable mortality
This study estimates premature deaths and hospitaliza-
tions for Canadians aged 69 years and younger and pro-
vides an overview of the 2002 estimated volume of alcohol
exposure in Canada by sex- and age-group. As expected,
men consumed on average more than women, and alcohol
consumption decreased with age.
Table 5 provides estimates of alcohol-attributable deaths
— deaths caused or prevented by alcohol consumption. In
Canada in 2002, there were 1631 net alcohol-attributable
premature deaths estimated, 1155 deaths among men and
476 among women. These numbers were derived by multi-
plying AAFs with number of deaths for each category to
produce numbers with decimals. As a result, there may be
minor rounding errors after collapsing numbers across dif-
ferent categories.
The 1631 alcohol-attributable deaths constituted 2.4% of
the deaths in Canada for people aged 69 years and
younger. These were net figures, and the estimates of
deaths prevented by alcohol have been taken into account.
There were 2577 deaths (1906 men and 672 women) attrib-
utable to alcohol and 947 deaths (751 men and 195 women)
prevented by alcohol consumption. Figures were calculat-
ed by using the epidemiological procedure previously
described.
Moderate drinking (category I, less than 20g per day of
pure alcohol for women and less than 40g per day for men)
was associated with 25% of deaths caused by alcohol con-
sumption and 85% of deaths prevented by alcohol con-
sumption. In this group of moderate drinkers, the deaths
prevented (n = 827) outnumbered deaths caused (n = 677)
by alcohol use.
Among premature deaths caused by alcohol, malignant
neoplasms accounted for 891 deaths (608 men and 283
women), and digestive diseases accounted for 881 deaths
(663 men and 218 women) (Table 3). Among deaths pre-
vented by alcohol for those aged 69 and younger, 788 pre-
vented deaths were ascribed to ischemic heart disease (678
men and 110 women).
Figure 1 gives an overview of deaths prevented and
caused by alcohol. Of the deaths caused by alcohol, includ-
ing detrimental effects of alcohol on some cardiovascular
diseases, cancer (34.6%) and digestive diseases (34.2%)
had the highest proportions of deaths caused by alcohol.
Alcohol-attributable PYLL
In 2002, the PYLL rate for Canada for premature deaths
due to alcohol was 196 per 100,000 for men and 92 per
100,000 for women aged 15 to 69 (Table 4). For every pop-
ulation of 100,000, there was a potential net loss of 196
years of life among men and 92 years of life among women
as a result of premature death due to alcohol consumption.
In total, 42,996 potential years of life were lost due to alco-
hol in Canada in 2002.
Alcohol-attributable hospitalizations
Table 6 provides estimates of alcohol-attributable diag-
noses for those aged 69 and younger, and Table 7 shows
AAFs applied to hospital data to estimate alcohol-attribut-
able fractions and mean age at hospital diagnosis. In
Canada for fiscal year 2002 to 2003, 91,970 alcohol-attrib-
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Figure 1. Alcohol-attributable chronic-disease mortality in people aged 69
years or younger in Canada, 2002.
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utable diagnoses among hospital diagnoses from acute
care facilities were estimated and accounted for 65,161
hospital separations for men and 26,809 for women. These
numbers were derived by multiplying AAFs with number
of diagnoses for each category to produce numbers with
decimals. As a result, there may be minor rounding errors
after collapsing numbers across categories.
Figure 2 gives an overview of alcohol-attributable chron-
ic disease diagnoses. The number of diagnoses (91,970) is a
net figure and includes estimates of hospital separations
prevented by alcohol consumption. There were 124,621
acute-care hospital diagnoses (hospital separations for
89,022 men and 35,599 women) caused by alcohol and
32,651 hospital diagnoses (23,861 men and 8790 women)
prevented by alcohol consumption. Among acute-care hos-
pital diagnoses attributable to alcohol, neuropsychiatric
conditions accounted for 49.9%, cardiovascular disease
33.7%, digestive diseases 13.0%, and cancer (malignant
neoplasms) 3.4% of diagnoses (Table 6).
Discussion
This analysis presents the main associations between
alcohol consumption and death and hospitalization due to
chronic disease in Canada in 2002. General limitations of
the study include the fact that it relies on secondary analy-
sis of existing data, such as official statistics, and these
sources have limitations and potential errors. As noted
previously, the Canadian Addiction Survey, although it
had a modest response rate, was the best resource avail-
able to calculate average alcohol consumption by age and
sex. People aged 70 and older were excluded from the
analysis because there is less confidence in diagnoses
among this age group. The assumption that alcohol-attrib-
utable relative risks as seen through meta-analyses are
transferable between countries may introduce error. Based
on meta-analyses used and their systematic exploration of
variance, the chronic disease bias may not be large for a
country like Canada (24,19,41).
Another potential bias is that detailed hospitalization
data were missing for three provinces and one territory.
Because current analyses did not focus on provincial com-
parisons, the effect is probably minimal. The adjustment
for adult per capita alcohol consumption may result in an
overestimate because underlying epidemiological esti-
mates were usually not adjusted. In Rehm et al (26), the
authors quantified potential overestimation for health
effects of alcohol and came to the conclusion that this effect
for Canada is limited. Consequently, data are presented
with adjustment to be comparable with mainline research
such as the WHO Comparative Risk Assessment within
the Global Burden of Disease project (1,2,4).
International research, including the WHO Global
Burden of Disease study (1), show that alcohol is a risk fac-
tor for numerous malignant neoplasms, neuropsychiatric
conditions, cardiovascular diseases, and digestive diseases
in both developed and developing countries. The number of
premature deaths associated with alcohol varies greatly
between general categories and specific conditions within a
category. Digestive diseases and malignant neoplasms are
6 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/oct/05_0009.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
Figure 2. Alcohol-attributable chronic disease diagnoses in population aged
69 years or younger in Canada, 2002
implicated in similar numbers of alcohol-attributable pre-
mature deaths in Canada in 2002, and these disease cate-
gories are followed by neuropsychiatric conditions.
However, an overall protective effect was estimated for
cardiovascular disease mortality.
A somewhat different picture emerges when focusing on
hospital diagnoses. The greatest numbers of alcohol-attrib-
utable conditions in the hospital diagnoses category are
neuropsychiatric conditions associated with alcohol use.
These are followed by cardiovascular diseases, digestive
diseases, and malignant neoplasms. There are also sub-
stantial alcohol-attributable treatments of neuropsychi-
atric conditions in specialized treatment systems outside of
acute-care hospitals.
AAFs generally show at least double the number of
deaths or hospitalizations among men compared with
women. By age group, the absolute number of deaths is
greatest among those aged 45 to 59, followed by those aged
60 to 69. There is a similar age-specific pattern for hospi-
tal diagnoses. Total PYLL are estimated at more than
42,000 in Canada for 2002. Alcohol-attributable chronic
diseases impact many people during their adult productive
years as well as young adults and youth. There are sub-
stantial social costs and economic burdens related to diag-
noses, treatment, medication, and care.
The findings in this study are generally in line with
international research on alcohol and chronic disease as
reported in the WHO Global Burden of Disease project
(1,2,3) and with analyses of causes of death in the United
States (42). In developed countries, such as Canada and
the United States, alcohol is a noteworthy risk factor for
chronic and acute disease, disability, and death. The
WHO Global Burden of Disease project estimated that in
developed countries alcohol was responsible for 9.2% of
burden of disease compared with 12.2% from tobacco and
10.9% from high blood pressure. The estimated contribu-
tion from alcohol was greater than that from high choles-
terol, high body mass, low fruit and vegetable intake, or
physical inactivity (1,2).
Effective interventions and policies are needed if alcohol-
attributable chronic diseases are to be reduced. Babor et al
(15) have provided an evidence-based analysis of interven-
tions and alcohol policies that have been shown to be effec-
tive in controlling the damage of chronic disease and other
harm associated with alcohol use. Their analysis examined
hundreds of published evaluations of interventions and
rated them on the following four criteria: 1) evidence of
effectiveness, 2) breadth of research report, 3) assessment
across cultures, and 4) costs to implement. Their analysis
took into account the target group in general, adverse side
effects, population reach (e.g., number of people affected by
the intervention), and political and economic feasibility.
The Babor et al assessment pointed to several alcohol-
related policies that are effective in controlling and
reducing harm from alcohol consumption and that are
also relevant in reducing alcohol-related chronic disease.
Their study included information on measures that control
access to alcohol (e.g., increased real price of alcoholic bev-
erages, lower density of outlets, government alcohol retail-
ing systems), server interventions to prevent service to
intoxicated patrons, and brief interventions (short counsel-
ing sessions) directed at high-risk drinkers. An increase in
real price of alcoholic beverages has been shown to reduce
not only the consumption of moderate drinkers but also the
consumption of high-risk drinkers as indicated by declin-
ing cirrhosis mortality (43). The Babor et al research (15)
and supporting work (44–46) indicate that alcohol access
control has a preventive impact at the population level for
men and women. Access control measures have also been
found to have beneficial impacts on specific sectors of a
population, such as occasional high-risk drinkers, chronic
heavy drinkers, and youth. In general, control measures
have greater impact on high-risk drinkers than on moder-
ate drinkers (15,44,46).
Research by Norström based on European and Canadian
data (7) has shown that at the population level, cardiovas-
cular mortality levels are not reduced by an increasing rate
of alcohol consumption nor elevated by lowering consump-
tion rate. At the population level, there may be no net ben-
efits for cardiovascular disease for those with a higher alco-
hol consumption level but an increased risk of both chron-
ic and acute damage (7,15).
Additional prevention-based evaluations are needed to
assess whether public health benefits of controls on access
to alcohol can be further enhanced by combining control
measures with other targeted interventions (e.g., server
interventions in establishments that sell alcohol and brief
interventions for high-risk drinkers who come into contact
with health facilities). Population-level interventions could
be combined with targeted alcohol awareness messages
delivered by health experts and their combined impact
assessed. Physicians, nurses, and other health care
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providers should be encouraged to advise patients routine-
ly about the risks for chronic disease associated with alco-
hol consumption when they do routine patient monitoring.
Both population-level phenomena (e.g., overall per capi-
ta consumption, societal prevalence of high-risk drinking)
and individual drinking behaviors are important consider-
ations for alcohol-related prevention initiatives. Efforts to
prevent chronic disease need to address risk factors,
including alcohol consumption, through focused resources
and program coordination in ways that ensure initiatives
are informed by epidemiological evidence. Because there is
a rising rate of alcohol consumption and high-risk drinking
in Canada, increased damage from alcohol is expected.
Effective policy, intervention, and prevention efforts are
needed, as is public recognition of alcohol as a contributor
to chronic disease. Medical, health care, and public health
professionals have important roles in drawing attention to
alcohol damage and other risk factors for chronic disease
and in supporting effective interventions.
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Tables
Table 1. Alcohol-attributable Chronic Disease Categories, Sources for Determining Risk Relations, and Relative Risk (RR),
Including Alcohol-attributable Fractions (AAFs), Canada, 2002
Malignant neoplasms
Mouth and oropharynx cancer C00-C14 (19) 1.45 1.45 1.85 1.85 5.39 5.39
Esophageal cancer C15 (19) 1.07 1.04 1.15 1.08 1.32 1.16
Liver cancer C22 (19) 1.80 1.80 2.38 2.38 4.36 4.36
Laryngeal cancer C32 (19) 1.45 1.45 3.03 3.03 3.60 3.60
Breast cancer
<45 y C50 (20) NA 1.15 NA 1.41 NA 1.46
>45 y C50 (20) NA 1.14 NA 1.38 NA 1.62
Other cancers D00-D48 (3) 1.10 1.10 1.30 1.30 1.70 1.70
Type 2 diabetes mellitus E10-E14 (19) 0.99 0.92 0.57 0.87 0.73 1.13
Neuropsychiatric conditions
Alcoholic psychoses F10.0, F10.3-F10.9 100% AAFe — — — — — — 
Alcohol abuse F10.1 100% AAFe — — — — — —  
Alcohol dependence syndrome F10.2 100% AAFe — — — — — —  
Unipolar major depressiond F32-F33 (3) — — — — — —  
Degeneration of nervous system G31.2 100% AAFe — — — — — — 
due to alcohol
Epilepsy G40-G41 (19) 1.23 1.34 7.52 7.22 6.83 7.52
Alcoholic polyneuropathy G62.1 100% AAFee — — — — — —  
Cardiovascular diseases
Hypertensive disease I10 - I15 (21) 1.15 1.33 1.53 2.04 2.19 2.91
Ischemic heart disease I20-I25 (3,21) 0.82 0.82 0.83 0.83 1.00 1.12
Alcoholic cardiomyopathy I42.6 100% AAFe — — — — — —  
Cardiac arrhythmias I47-I49 (19) 1.51 1.51 2.23 2.23 2.23 2.23
Heart failure and ill-defined I50-I52, I23, I25.0, — — — — — — 
complications of heart diseasef I97.0, I97.1, I98.1
Cerebrovascular disease I60-I69 (22) 0.97 0.70 1.08 0.80 1.76 1.96
VOLUME 3: NO. 4
OCTOBER 2006
www.cdc.gov/pcd/issues/2006/oct/05_0009.htm • Centers for Disease Control and Prevention 11
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
Alcohol Consumption Level, RR
Drinking Category Ia Drinking Category IIb Drinking Category IIIc
Sources for
Chronic Disease Categories ICD-10 code Meta-analyses Men Women Men Women Men Women
ICD-10 indicates International Classification of Diseases, 10th Revision; NA, not applicable. 
aDrinking category I, .25 to < 20 grams of alcohol per day for women and .25 to < 40 grams of alcohol per day for men. 
bDrinking category II, 20 to < 40 grams of alcohol per day for women and 40 to < 60 grams of alcohol per day for men. 
cDrinking category III, > 40 grams of alcohol per day for women and > 60 grams of alcohol per day for men. 
dFor depression, a direct approach was used to estimate AAFs; therefore, RRs are not applicable (3). 
eDisease is alcohol-induced; therefore, AAFs are 100%, and RRs are not applicable. 
fThis unspecific category has no identification of underlying pathology, and the relationship between average volume of alcohol consumption cannot be
determined by usual meta-analysis.
(Continued on next page)
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Cardiovascular diseases (continued)
Ischemic stroke I60-I62 (22) 0.94 0.66 1.13 0.84 1.19 1.53
Hemorrhagic stroke I63-I66 (22) 1.12 0.74 1.40 1.04 1.54 1.94
Esophageal varices I85 (19) 1.26 1.26 9.54 9.54 9.54 9.54
Digestive diseases
Alcoholic gastritis K29.2 100% AAFe — — — — — —  
Cirrhosis of the liver K70, K74 (3) 1.30 1.30 9.05 9.50 13.00 13.00
Cholelithiasis K80 (19) 0.82 0.82 0.68 0.68 0.50 0.50
Acute and chronic pancreatitis K85, K86.1 (21) 1.30 1.30 1.80 1.80 3.20 1.80
Chronic pancreatitis, K86.0 100% AAFe — — — — — —
alcohol induced
ICD-10 indicates International Classification of Diseases, 10th Revision; NA, not applicable. 
aDrinking category I, .25 to < 20 grams of alcohol per day for women and .25 to < 40 grams of alcohol per day for men. 
bDrinking category II, 20 to < 40 grams of alcohol per day for women and 40 to < 60 grams of alcohol per day for men. 
cDrinking category III, > 40 grams of alcohol per day for women and > 60 grams of alcohol per day for men. 
dFor depression, a direct approach was used to estimate AAFs; therefore, RRs are not applicable (3). 
eDisease is alcohol-induced; therefore, AAFs are 100%, and RRs are not applicable. 
fThis unspecific category has no identification of underlying pathology, and the relationship between average volume of alcohol consumption cannot be deter-
mined by usual meta-analysis.
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Table 1. (continued) Alcohol-attributable Chronic Disease Categories, Sources for Determining Risk Relations, and Relative
Risk (RR), Including Alcohol-attributable Fractions (AAFs), Canada, 2002
Alcohol Consumption Level, RR
Drinking Category Ia Drinking Category IIb Drinking Category IIIc
Sources for
Chronic Disease Categories ICD-10 code Meta-analyses Men Women Men Women Men Women
Table 2. Alcohol Consumption Levels of Respondents to the 2003 2004 Canadian Addiction Surveya (N = 13,909) by Age and
Sexb
15–29 30.2 59.0 51.6 34.8 8.7 3.2 9.4 3.0
30–44 35.1 62.1 48.6 31.0 8.2 4.3 8.1 2.6
45–59 40.0 65.3 45.5 27.1 7.6 5.5 6.8 2.2
60–69 45.0 68.4 42.4 23.2 7.1 6.6 5.5 1.8
70–79 48.3 70.5 40.4 20.7 6.7 7.4 4.6 1.5
>80 51.5 72.6 38.3 18.1 6.4 8.2 3.8 1.1
All ages 40.4 66.9 46.8 24.9 6.5 6.3 6.3 1.9
aSource: Canadian Centre on Substance Abuse (25). 
bCharacteristics of the Canadian Addiction Survey sample were weighted to correspond to age and sex distribution of the Canadian population. 
cAverage volume of alcohol consumption was derived from a quantity frequency measure and adjusted by adult per capita consumption (26). Quantity of
alcohol was assessed in beverage-specific drinks per usual occasion (25). 
dAbstainer or very light drinker category, 0 to < .25 grams of alcohol per day for men and women. 
eDrinking category I, .25g to < 20g of alcohol per day for women and .25g to < 40g for men. 
fDrinking category II, 20g to < 40g of alcohol for women and 40g to < 60g for men. 
gDrinking category III, > 40g of alcohol for women and  > 60g for men.
Table 3. Alcohol-attributable Fractions (AAFs)a and Mean Age at Death in Canada, 2002
Detrimental effectsb
Malignant neoplasms (3.4%) 15.8 4.0 57.3 55.7
Mouth and oropharynx cancer 20.5 8.4 56.9 56.4
Esophageal cancer 19.2 7.1 56.9 57.2
Liver cancer 16.1 7.6 56.9 59.1
Laryngeal cancer 19.3 15.4 59.1 59.1
Breast cancer 0 3.3 0 54.5
Other cancers 3.2 1.0 54.3 53.8
Neuropsychiatric conditions (49.9%) 57.4 35.5 52.1 52.3
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Alcohol Consumption Level,c %
Abstainer or Very Light Drinkerd Drinking Category Ie Drinking Category IIf Drinking Category IIIg
Age Categories, y Men Women Men Women Men Women Men Women
NA indicates not applicable. 
aAAF refers to the number of alcohol-related deaths divided by the overall number of deaths. 
bNumbers were derived by multiplying AAFs with number of diagnoses and result in numbers with decimals; there may be rounding errors. A negative num-
ber indicates that more deaths were prevented than caused by alcohol for the respective disease condition.
(Continued on next page)
AAF (%) Aged 69 and Younger Mean Age at Death, y
Chronic Disease Categories Men Women Men (n = 89,022) Women (n = 35,599)
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Detrimental effectsb (continued)
Alcoholic psychoses 100 100 51.8 54.4
Alcohol abuse 100 100 53.0 49.9
Alcohol dependence syndrome 100 100 54.7 54.9
Unipolar major depression 1.1 0.1 48.0 54.7
Degenerative nervous system due to alcohol 100 100 59.1 52.0
Epilepsy 39.4 18.7 41.2 46.7
Alcoholic polyneuropathy 100 100 NA NA
Cardiovascular diseases (33.7%) 2.5 0.3 54.8 56.5
Hypertensive disease 6.4 0.6 56.4 59.7
Alcoholic cardiomyopathy 100 100 52.7 56.4
Cardiac arrhythmias 7.0 1.4 53.7 54.6
Cerebrovascular disease 0.7 NA 56.2 NA
Hemorrhagic stroke 1.4 NA 59.1 NA
Esophageal varices 34.2 17.9 57.5 59.6
Digestive diseases (13.0%) 38.7 55.5 50.3 54.6
Alcoholic gastritis 100 100 58.3 64.5
Cirrhosis of the liver 41.3 26.4 55.6 54.5
Acute and chronic pancreatitis 13.5 3.4 54.4 56.4
Chronic pancreatitis, alcohol induced 55.6 66.7 50.0 52.0
Cholelithiasis -16.2 -8.6 49.8 42.8
Average mean age at death for detrimental effects 55.2 54.7
Beneficial effectsb
Type 2 diabetes mellitus -5.1 -2.5 56.9 57.7
Ischemic heart disease -3.1 -0.6 57.4 58.6
Cerebrovascular disease NA -0.7 NA 56.1
Ischemic stroke -0.2 -2.9 56.8 53.5
Hemorrhagic stroke NA -0.2 NA 59.6
Cholelithiasis -3.3 -0.8 58.9 54.3
Average mean age at death for beneficial effects 57.4 57.7
Average mean age at death for net effects 53.8 53.4
NA indicates not applicable. 
aAAF refers to the number of alcohol-related deaths divided by the overall number of deaths. 
bNumbers were derived by multiplying AAFs with number of diagnoses and result in numbers with decimals; there may be rounding errors. A negative num-
ber indicates that more deaths were prevented than caused by alcohol for the respective disease condition.
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Table 3. (continued) Alcohol-attributable Fractions (AAFs)a and Mean Age at Death in Canada, 2002
AAF (%) Aged 69 and Younger Mean Age at Death, y
Chronic Disease Categories Men Women Men (n = 89,022) Women (n = 35,599)
Table 4. Estimated Potential Years of Life Lost (PYLL) Attributable to Alcohol in Canada, 2002
Menab
15–29 25 1338
30–44 163 6519
45–59 550 14,378
60–69 417 6655
Total for men 1155 28,890
Womencd
15–29 7 402
30–44 75 3349
45–59 235 7191
60–69 160 3164
Total for women 477 14,106
Total 1632 42,996
aStandard life expectancy for men at birth is 76.0 years. 
bAlcohol-attributable years of life lost per 100,000 men is 196. 
cStandard life expectancy for women at birth is 81.5 years. 
dAlcohol-attributable years of life lost per 100,000 women is 92.
Table 5. Numbera of Chronic Disease Deaths Attributable to Alcohol by Sex, Age, and Disease Category in Canada, 2002
Detrimental effects
Malignant neoplasms (n = 891) 4 3 35 30 261 124 308 126
Mouth and oropharynx cancer 1 1 11 2 68 11 75 14
Esophageal cancer 1 0 11 2 91 9 105 17
Liver cancer 1 1 9 2 65 15 70 22
Laryngeal cancer 0 0 1 0 31 5 46 8
Breast cancer NA 1 NA 23 NA 81 NA 61
Other cancers 2 0 3 1 7 3 11 3
Neuropsychiatric conditions (n = 572) 16 3 86 25 188 69 145 40
Alcoholic psychoses 3 0 23 3 41 12 33 8
Alcohol abuse 0 0 15 9 36 14 24 6
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Age Groups in Years by Sex Alcohol-attributable Deaths (n) PYLL
No. of Deaths by Age and Sex (N = 2631)
15-29 y 30-44 y 45-59 y 60-69 y
Chronic Disease Categories Men Women Men Women Men Women Men Women
NA indicates not applicable. 
aNumbers were derived by multiplying alcohol-attributable fractions (AAFs) with number of deaths. Results are in numbers with decimals, and there may be
rounding errors. A negative number indicates that more deaths were prevented than caused by alcohol for the respective disease condition.
(Continued on next page)
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Detrimental effects (continued)
Alcohol dependence syndrome 2 0 26 6 92 32 78 21
Unipolar major depression 0 0 0 0 0 0 0 0
Degeneration of nervous system due to alcohol 0 0 0 0 3 1 4 0
Epilepsy 11 3 22 7 16 10 6 5
Alcoholic polyneuropothy 0 0 0 0 0 0 0 0
Cardiovascular diseases (n = 233) 4 1 24 3 88 12 84 18
Hypertensive disease 0 0 4 0 20 2 23 5
Alcoholic cardiomyopathy 0 0 5 1 22 3 8 4
Cardiac arrhythmias 3 1 10 2 26 6 27 7
Cerebrovascular disease 1 NA 5 NA 16 NA 23 NA
Hemorrhagic stroke 0 NA 3 NA 16 NA 35 NA
Esophageal varices 0 0 0 0 3 1 3 1
Digestive diseases (n = 882) 3 1 68 33 320 97 272 88
Alcoholic gastritis 0 0 0 0 1 0 1 1
Cirrhosis of the liver 2 1 62 32 305 93 259 84
Acute and chronic pancreatitis 1 0 3 1 9 2 10 3
Chronic pancreatitis, alcohol induced 0 0 3 0 5 2 2 0
Total detrimental effects (n = 2631) 27 8 213 91 858 301 808 271
Beneficial effects
Type 2 diabetes mellitus -1 0 -7 -1 -27 -6 -38 -10
Ischemic heart disease -2 0 -44 -6 -281 -37 -352 -67
Cerebrovascular disease NA -1 NA -8 NA -23 NA -34
Ischemic stroke 0 -1 0 -9 -1 -21 -1 -18
Hemorrhagic stroke NA 0 NA -1 NA -4 NA -9
Cholelithiasis 0 0 0 0 -1 0 -1 0
Total beneficial effects (n = -945) -2 -1 -50 -16 -308 -67 -390 -111
Total net effects 25 7 163 75 550 235 417 160
NA indicates not applicable. 
aNumbers were derived by multiplying alcohol-attributable fractions (AAFs) with number of deaths. Results are in numbers with decimals, and there may be
rounding errors. A negative number indicates that more deaths were prevented than caused by alcohol for the respective disease condition.
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Table 5. (continued) Numbera of Chronic Disease Deaths Attributable to Alcohol by Sex, Age, and Disease Category in
Canada, 2002
No. of Deaths by Age and Sex (N = 2631)
15-29 y 30-44 y 45-59 y 60-69 y
Chronic Disease Categories Men Women Men Women Men Women Men Women
Table 6. Number of Chronic Disease Hospital Diagnosesa by Sex, Age, and Disease Category in Canada, 2002
Detrimental effects
Malignant neoplasms (n = 4261) 34 38 216 329 1088 904 1030 623
Mouth and oropharynx cancer 19 15 121 48 437 125 304 85
Esophageal cancer 3 0 30 7 259 40 286 61
Liver cancer 8 3 39 12 248 48 214 61
Laryngeal cancer 2 1 21 5 134 28 210 31
Breast cancer 0 9 0 195 0 564 0 336
Other cancers 1 9 4 62 9 99 16 49
Neuropsychiatric conditions (n = 62,128) 6222 3765 13,358 7069 15,760 6311 7091 2553
Alcoholic psychoses 1690 950 3249 1634 3717 1369 1439 455
Alcohol abuse 1954 1416 3384 1989 3194 1440 1343 477
Alcohol dependence syndrome 1088 689 4524 2448 6554 2438 3249 1037
Unipolar major depression 713 179 1000 281 892 288 344 127
Degenerative nervous system due to alcohol 4 0 33 28 221 62 178 74
Epilepsy 770 531 1157 682 1155 703 516 376
Polyneuropathy 4 0 11 7 26 11 22 7
Cardiovascular diseases (n = 42,000) 666 262 2990 944 13,173 3460 15,592 4913
Hypertensive disease 295 76 1805 491 8480 2129 9453 2752
Alcoholic cardiomyopathy 4 0 77 7 262 32 222 28
Cardiac arrhythmia 320 178 934 416 3768 1190 5386 2051
Cerebrovascular disease 24 NA 76 NA 281 NA 352 NA
Hemorrhagic stroke 19 NA 77 NA 399 NA 615 NA
Esophageal varices 23 8 98 30 382 109 180 81
Digestive diseases (n = 16,232) 516 291 2713 1090 5714 1899 2859 1149
Alcoholic gastritis 136 65 485 195 523 207 213 68
Cirrhosis of the liver 93 51 1108 493 3702 1163 2067 841
Acute and chronic pancreatitis 239 150 688 274 939 377 416 194
Chronic pancreatitis, alcohol induced 48 25 432 128 580 152 163 46
Total detrimental effects (n = 124,621) 7438 4355 19,277 9432 35,735 12,574 26,572 9238
Beneficial effects
Type 2 diabetes mellitus -229 -111 -629 -252 -1958 -642 -1914 -694
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No. of Diagnoses by Age in Years and Sex (N = 124,621)
15-29 y 30-44 y 45-59 y 60-69 y
Chronic Disease Categories Men Women Men Women Men Women Men Women
aDiagnoses data were obtained from the Hospital Morbidity Database at the Canadian Institute of Health Information (40). Aggregated data for each condi-
tion was estimated based on total population and combined data of available provinces and territories. (Provinces included are Alberta, British Columbia,
Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan. Territories included are Yukon and Northwest Territories. ICD-10 data were
unavailable for Quebec, Manitoba, New Brunswick, and Nunavut.)
(Continued on next page)
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Beneficial effects (continued)
Ischemic heart disease -46 -13 -1379 -238 -8052 -1420 -7563 -1916
Cerebrovascular NA -48 NA -132 NA -378 NA -489
Ischemic stroke 0 -23 -2 -61 -7 -124 -8 -96
Hemorrhagic stroke NA -14 NA -34 NA -113 NA -160
Cholelithiasis -157 -547 -492 -752 -843 -763 -600 -398
Total beneficial effects (n = 32,651) -432 -719 -2500 -1373 -10,853 -3203 -10,077 -3495
Total net effects (n = 91,970) 7006 3637 16,777 8059 24,883 9371 16,495 5743
aDiagnoses data were obtained from the Hospital Morbidity Database at the Canadian Institute of Health Information (40). Aggregated data for each condi-
tion was estimated based on total population and combined data of available provinces and territories. (Provinces included are Alberta, British Columbia,
Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan. Territories included are Yukon and Northwest Territories. ICD-10 data were
unavailable for Quebec, Manitoba, New Brunswick, and Nunavut.)
Table 7. Alcohol-attributable Fractions (AAFs)a and Mean Age at Chronic Disease Hospital Diagnosisb in Canada, 2002
Detrimental effects
Malignant neoplasms total 35.2 8.3 55.6 52.9
Mouth and oropharynx cancerc 34.9 20.5 53.6 51.7
Esophageal cancer 39.8 26.0 57.2 58.1
Liver cancer 31.6 21.0 55.6 55.8
Laryngeal cancer 44.7 31.7 58.1 56.4
Breast cancer 0 6.7 0 60.7
Other cancers 9.9 5.6 55.9 49.3
Neuropsychiatric conditions total 60.2 29.8 45 42.5
Alcoholic psychosis 100 100 43.9 41.3
Alcohol dependence syndrome 100 100 48.1 45.3
Alcohol abuse 100 100 42.6 39.5
Unipolar major depression 11.7 2.1 41.1 42.9
Degenerative nervous system due to alcohol 100 100 56.7 55.1
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Table 6. (continued) Number of Chronic Disease Hospital Diagnosesa by Sex, Age, and Disease Category in Canada, 2002
No. of Diagnoses by Age in Years and Sex (N = 124,621)
15-29 y 30-44 y 45-59 y 60-69 y
Chronic Disease Categories Men Women Men Women Men Women Men Women
AAF (%) Age 69 All Ages Mean Age at Death, y
Chronic Disease Categories Men Women Men Women
aDiagnoses data were obtained from the Hospital Morbidity Database at the Canadian Institute of Health Information (40). Aggregated data for each condi-
tion was estimated based on total population and combined data of available provinces and territories. (Provinces included are Alberta, British Columbia,
Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan. Territories included are Yukon and Northwest Territories. ICD-10 data were
unavailable for Quebec, Manitoba, New Brunswick, and Nunavut.)
(Continued on next page)
Detrimental effects (continued)
Epilepsy 38.4 27.2 42.5 42.6
Alcoholic polyneuropathy 100 100 52.1 51.4
Cardiovascular diseases total 21.9 8.9 56 56.1
Hypertensive disease 25.6 8.5 56.1 56.5
Alcoholic cardiomyopathy 100 100 54.7 55.6
Cardiac arrhythmias 27.7 18.1 56.2 55.7
Cerebrovascular disease 3.8 NA 55.5 NA
Hemorrhagic stroke 10.2 NA 57.4 NA
Esophageal varices 55.4 39.8 52.1 53.4
Digestive diseases total 51.5 30.1 50.3 49.6
Alcoholic gastritis 100 100 45.6 44.5
Cirrhosis of liver 60.1 44.4 52.9 52.6
Acute and chronic pancreatitis 26 12.3 46.6 45.8
Chronic pancreatitis (alcohol-induced) 100 100 47.1 46
Average mean age at diagnosis for detrimental alcohol-related effects 50.0 47.6
Beneficial effects
Type 2 diabetes mellitus -9.4 -5.2 32.2 26.0
Ischemic heart disease -10.2 -5.6 56.3 57.6
Cerebrovascular NA -7.3 NA 54.6
Ischemic stroke -0.5 -9.4 55.9 50.7
Hemorrhagic stroke NA -4.6 NA 55.3
Cholelithiasis -16.2 -8.6 49.8 42.8
Average mean age at diagnosis for beneficial alcohol-related effects 48.7 43.5
NA indicates not applicable.
aAlcohol-attributable fractions (AAFs) refer to number of alcohol-related diagnoses divided by overall number of diagnoses.
bDiagnoses data were obtained from the Hospital Morbidity Database at the Canadian Institute of Health Information (40). Aggregated data for each condi-
tion was estimated based on total population and combined data of available provinces and territories. Provinces included are Alberta, British Columbia,
Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan. Territories included are Yukon and Northwest Territories. ICD-10 data were
unavailable for Quebec, Manitoba, New Brunswick, and Nunavut.
cNumbers were derived by multiplying AAFs with number of diagnoses; results are in numbers with decimals, and there may be rounding errors. A negative
number indicates that more hospital diagnoses were prevented than caused by alcohol for the respective disease condition.
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Table 7. (continued) Alcohol-attributable Fractions (AAFs)a and Mean Age at Chronic Disease Hospital Diagnosisb in Canada,
2002
AAF (%) Age 69 All Ages Mean Age at Death, y
Chronic Disease Categories Men Women Men Women
